Roivant Sciences Ltd.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2020 | — | — | $2.27B |
| Jun 2020 | — | — | $2.31B |
| Sep 2020 | — | — | $2.39B |
| Dec 2020 | — | — | $2.15B |
| Mar 2021 | $527.7M | $2.59B | $2.06B |
| Jun 2021 | $474.9M | $2.45B | $2.00B |
| Sep 2021 | $652.0M | $3.10B | $2.50B |
| Dec 2021 | $529.6M | $2.80B | $2.21B |
| Mar 2022 | $523.7M | $2.59B | $2.06B |
| Jun 2022 | $822.5M | $2.60B | $1.94B |
| Sep 2022 | $701.4M | $2.22B | $1.60B |
| Dec 2022 | $775.8M | $2.20B | $1.53B |
| Mar 2023 | $782.0M | $2.39B | $1.68B |
| Jun 2023 | $802.5M | $2.14B | $1.43B |
| Sep 2023 | $739.9M | $2.07B | $1.41B |
| Dec 2023 | $728.1M | $7.31B | $6.67B |
| Mar 2024 | $774.0M | $7.22B | $6.49B |
| Jun 2024 | $601.2M | $6.50B | $5.68B |
| Sep 2024 | $626.0M | $6.21B | $1.96B |
| Dec 2024 | $256.4M | $5.79B | $1.99B |
| Mar 2025 | $249.7M | $5.44B | $2.72B |
| Jun 2025 | $216.7M | $5.03B | $1.24B |
| Sep 2025 | $257.1M | $5.06B | $1.24B |
| Dec 2025 | $251.1M | $5.23B | $1.48B |
| Mar 2026 | $416.3M | $5.71B | $1.42B |
| Jun 2026 | $384.6M | $5.31B | $1.25B |